AR054253A1 - Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo - Google Patents
Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismoInfo
- Publication number
- AR054253A1 AR054253A1 AR20060101538A ARP060101538A AR054253A1 AR 054253 A1 AR054253 A1 AR 054253A1 AR 20060101538 A AR20060101538 A AR 20060101538A AR P060101538 A ARP060101538 A AR P060101538A AR 054253 A1 AR054253 A1 AR 054253A1
- Authority
- AR
- Argentina
- Prior art keywords
- association
- treatment
- paludism
- railway
- ferroquine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Tiene por objeto una asociacion, que comprende ferroquina, en forma de base libre, de sal, de hidrato o de solvato, y un derivado de artemisinina. Tiene igualmente por objeto una composicion farmacéutica que comprende ferroquina, en forma de una de sus sales farmacéuticamente aceptables, un hidrato o un solvato de la ferroquina, y al menos un derivado de artemisinina. Tiene también por objeto la utilizacion de tal asociacion para la preparacion de un medicamento destinado al tratamiento o la prevencion del paludismo. Tiene por ultimo por objeto un kit para e tratamiento o la prevencion del paludismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0503932A FR2884715B1 (fr) | 2005-04-20 | 2005-04-20 | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054253A1 true AR054253A1 (es) | 2007-06-13 |
Family
ID=35385843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20060101538A AR054253A1 (es) | 2005-04-20 | 2006-04-19 | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20120258945A1 (es) |
| EP (1) | EP1874293A1 (es) |
| JP (1) | JP5148478B2 (es) |
| KR (1) | KR20080009088A (es) |
| CN (2) | CN101163470A (es) |
| AP (1) | AP2782A (es) |
| AR (1) | AR054253A1 (es) |
| AU (1) | AU2006238506B2 (es) |
| BR (1) | BRPI0610851A2 (es) |
| CA (1) | CA2605385A1 (es) |
| CR (1) | CR9425A (es) |
| DO (1) | DOP2006000092A (es) |
| EA (1) | EA012630B1 (es) |
| FR (1) | FR2884715B1 (es) |
| GT (1) | GT200600157A (es) |
| HN (1) | HN2006015130A (es) |
| IL (1) | IL186048A0 (es) |
| MA (1) | MA29451B1 (es) |
| MX (1) | MX2007012645A (es) |
| MY (1) | MY145581A (es) |
| NO (1) | NO20075920L (es) |
| NZ (1) | NZ562117A (es) |
| PA (1) | PA8669801A1 (es) |
| PE (2) | PE20110119A1 (es) |
| SG (1) | SG161270A1 (es) |
| TN (1) | TNSN07359A1 (es) |
| TW (1) | TWI387456B (es) |
| UA (1) | UA96414C2 (es) |
| WO (1) | WO2006111647A1 (es) |
| ZA (1) | ZA200708800B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2926993B1 (fr) | 2008-02-06 | 2011-03-11 | Sanofi Aventis | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme |
| FR2952823B1 (fr) * | 2009-10-30 | 2012-04-20 | Sanofi Aventis | Utilisation de la ferroquine dans le traitement ou la prevention du paludisme |
| FR2951945B1 (fr) | 2009-11-05 | 2013-08-09 | Sanofi Aventis | Composition pharmaceutique |
| FR2961209B1 (fr) * | 2010-06-11 | 2013-03-01 | Sanofi Aventis | Procede de synthese de la ferroquine par amination reductrice convergente. |
| FR2989588A1 (fr) * | 2012-04-19 | 2013-10-25 | Centre Nat Rech Scient | Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae |
| CA2928866C (en) | 2013-11-08 | 2021-11-09 | Exthera Medical Corporation | Methods for diagnosing infectious diseases using adsorption media |
| CN105250295B (zh) * | 2014-07-07 | 2018-12-25 | 广州中医药大学科技产业园有限公司 | 一种联合用药物及其作为免疫调节剂的应用 |
| WO2017015344A1 (en) * | 2015-07-20 | 2017-01-26 | University Of Vermont And State Agricultural College | Use of cymanquine compounds as antimalarial agents |
| CN107802755A (zh) * | 2017-11-08 | 2018-03-16 | 江西龙卿堂科技有限公司 | 一种具有防蚊防疟作用的青蒿软膏 |
| KR102073961B1 (ko) * | 2018-11-16 | 2020-02-05 | (주)프론트바이오 | 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 |
| BR112022026791A2 (pt) * | 2020-07-09 | 2023-05-02 | Ceva Sante Animale | Composições veterinárias para prevenção e/ou tratamento de leishmaniose |
| US20240207251A1 (en) * | 2021-04-26 | 2024-06-27 | Min Bo SHIM | Pharmaceutical composition containing artesunate or salt thereof and pyronaridine or salt thereof, for antipyresis, anti-inflammatory efficacy, anti-viral efficacy and treatment or prevention of covid-19, and method using same |
| CN113952360B (zh) * | 2021-09-14 | 2023-03-10 | 上海交通大学 | 一种亚铁离子在治疗疟疾的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN166154B (es) * | 1987-05-08 | 1990-03-24 | Hoechst India | |
| ZA200602031B (en) * | 2003-09-04 | 2007-05-30 | Cipla Ltd | Antimalarial compositions and process thereof |
-
2005
- 2005-04-20 FR FR0503932A patent/FR2884715B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-17 PE PE2010000537A patent/PE20110119A1/es not_active Application Discontinuation
- 2006-04-17 PE PE2006000399A patent/PE20061314A1/es not_active Application Discontinuation
- 2006-04-18 MY MYPI20061772A patent/MY145581A/en unknown
- 2006-04-18 EA EA200702282A patent/EA012630B1/ru not_active IP Right Cessation
- 2006-04-18 BR BRPI0610851-2A patent/BRPI0610851A2/pt not_active IP Right Cessation
- 2006-04-18 EP EP06743711A patent/EP1874293A1/fr not_active Withdrawn
- 2006-04-18 CA CA002605385A patent/CA2605385A1/fr not_active Abandoned
- 2006-04-18 ZA ZA200708800A patent/ZA200708800B/xx unknown
- 2006-04-18 NZ NZ562117A patent/NZ562117A/en not_active IP Right Cessation
- 2006-04-18 KR KR1020077024076A patent/KR20080009088A/ko active IP Right Grant
- 2006-04-18 CN CNA2006800130136A patent/CN101163470A/zh active Pending
- 2006-04-18 UA UAA200712809A patent/UA96414C2/ru unknown
- 2006-04-18 JP JP2008507122A patent/JP5148478B2/ja not_active Expired - Fee Related
- 2006-04-18 CN CN201210369240XA patent/CN102836163A/zh active Pending
- 2006-04-18 SG SG201002562-5A patent/SG161270A1/en unknown
- 2006-04-18 WO PCT/FR2006/000842 patent/WO2006111647A1/fr active Application Filing
- 2006-04-18 AP AP2007004211A patent/AP2782A/xx active
- 2006-04-18 AU AU2006238506A patent/AU2006238506B2/en not_active Ceased
- 2006-04-18 MX MX2007012645A patent/MX2007012645A/es active IP Right Grant
- 2006-04-19 AR AR20060101538A patent/AR054253A1/es unknown
- 2006-04-19 PA PA20068669801A patent/PA8669801A1/es unknown
- 2006-04-20 HN HN2006015130A patent/HN2006015130A/es unknown
- 2006-04-20 GT GT200600157A patent/GT200600157A/es unknown
- 2006-04-20 DO DO2006000092A patent/DOP2006000092A/es unknown
- 2006-04-20 TW TW095114167A patent/TWI387456B/zh not_active IP Right Cessation
-
2007
- 2007-09-18 IL IL186048A patent/IL186048A0/en unknown
- 2007-09-21 TN TNP2007000359A patent/TNSN07359A1/en unknown
- 2007-10-08 CR CR9425A patent/CR9425A/es unknown
- 2007-10-18 US US11/874,377 patent/US20120258945A1/en not_active Abandoned
- 2007-11-16 NO NO20075920A patent/NO20075920L/no not_active Application Discontinuation
- 2007-11-19 MA MA30375A patent/MA29451B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054253A1 (es) | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
| ECSP066950A (es) | Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2 | |
| ES2581331T3 (es) | Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática | |
| CO6491052A2 (es) | Compuestos espirociclicos que contienen notrogeno y su uso medicinal | |
| ECSP077401A (es) | Medicamentos que contienen compuestos de carbonilo y su uso | |
| HRP20080313A2 (en) | Methods for improving the pharmacokinetics of hiv integrase inhibitors | |
| PA8637301A1 (es) | Derivados de amino-5, 5-difenilimidazolona para la inhibicion de la b-secretasa | |
| ECSP088296A (es) | Compuestos terapéuticos | |
| ES2515168T3 (es) | Detección y tratamiento de la esquizofrenia | |
| AR058163A1 (es) | Medicamentos exhaltadores del deseo sexual que comprenden derivados de benzimidazolona | |
| CL2011000798A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| UY30460A1 (es) | Compuestos terapéuticos | |
| CR9737A (es) | Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) sus sales. | |
| CL2011000806A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| DOP2012000050A (es) | Nuevas composiciones de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil] piperazina | |
| ECSP088555A (es) | Composiciones farmacéuticas | |
| CO6531485A2 (es) | Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa | |
| CR20190144A (es) | Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos | |
| CL2011002233A1 (es) | Metodo para tratar o prevenir el cancer, que comprende administrar una combinacion farmaceutica sinergica de: a) (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopropan-1-sulfonamida y b) 3-(6,7-bis(2-metoxietoxi)quinazolin-4-ilamino)benzonitrilo; composicion farmaceutica; y kit farmaceutico. | |
| AR062390A1 (es) | Uso de derivados del 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas | |
| AR082875A1 (es) | (s)-(4-fluorofenil)(4-((5-metil-1h-pirazol-3-il)amino)quinazolin-2-il)metanol opticamente activo, composiciones farmaceuticas que lo contienen, metodo para prepararlo y uso del mismo como agentes anticancer o antiinflamatorio | |
| AR079049A1 (es) | Combinacion terapeutica que comprende un inhibidor de cdc7 y un agente antineoplasico | |
| CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
| NI201000135A (es) | Asociacion entre una sal de bis-tiazolio o uno de sus precursores y artemisinina o uno de sus derivados para el tratamiento del paludismo grave. | |
| PA8789101A1 (es) | Composición farmacéutica estable que comprende una sal de vinflunina hidrosoluble |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |